SMC Says Yes to Aubagio® (teriflunomide), a New Once Daily First-line Oral Treatment Available for People with an Active Relapsing Remitting Form of MS
Sys-Con Media, PR Newswire, 10 Mar 2014
Accessed on 11 Mar 2014 from http://www.sys-con.com/node/3005043.